Improving naltrexone response: An intervention for medical practitioners to enhance medication compliance in alcohol dependent patients

Journal of Addictive Diseases

Volumn 19, Issue 1, 2000, Pages 71-83

  Pettinati, Helen M ^a   Volpicelli, Joseph R ^a   Pierce, John D ^a   O'brien, Charles P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alcohol dependence; Compliance enhancement; Medication compliance; Naltrexone; Pharmacotherapy

Indexed keywords

ALCOHOL; NALTREXONE;

ALCOHOLISM; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE;

ADULT; ALCOHOLISM; AMBULATORY CARE; COMBINED MODALITY THERAPY; DAY CARE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; NALTREXONE; NARCOTIC ANTAGONISTS; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; TREATMENT OUTCOME;

EID: 0033846424     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v19n01_06     Document Type: Article

References (33)

1. Berg JS, Dischler J, Wagner DJ, Raia JJ, Palmer-Shevlin, N. Medication compliance: a healthcare problem. Ann Pharmacother. 1993; 27:S1-24.
2. Aagaard J, Vestergaard P, Maarbjerg K. Adherence to lithium prophylaxis, II: Multivariate analysis of clinical, social, and psychosocial predictors of nonadherence. Pharmacopsychiatry. 1988; 21:166-170.
3. Fawcett J. Compliance: definitions and key issues. J Clin Psychiatry. 1995; 56:4-8; discussion 9-10.
4. Greenberg RN. Overview of patient compliance with medication dosing: A literature review. ClinTher. 1984; 6:592-599.
5. Paykel ES. Psychotherapy, medication combinations, and compliance. J Clin Psychiatry. 1995; 56:24-30.
6. Forman L. Medication: reasons and interventions for noncompliance. J Psychosoc Nurs. 1993; 31:23-25.
7. Bebbington PE. The content and context of compliance. Int Clin Psychopharmacol. 1995; 9:41-50.
8. Gerbino PP. Forward. Medication compliance: A Healthcare problem. Ann Pharmacother. 1993; 27:S3-S4.
9. Keck PE, McElroy SL, Strakowski SM, et al. Factors associated with pharmacologic noncompliance in patients with mania. J Clin Psychiatry. 1996; 57:292-297.
10. Kelly GR, Scott JE, Mamon J. Medication compliance and health education among outpatients with chronic mental disorders. Med Care. 1990; 28:1181-1197.
11. Kent JH. The epidemiology of multidrug-resistant tuberculosis in the United States. Med Clin North Am. 1993; 77:1391-1409.
12. Sbarbaro JA, Sbarbaro JB. Compliance and supervision of chemotherapy of tuberculosis. Semin Respir Infect. 1994; 9:120-7.
13. Baekeland F, Lundwall L. Dropping out of treatment: A critical review. Psycho Bull. 1975; 5:738-783.
14. Pettinati HM, Belden PP, Evans BD, Ruetsch CR, Meyers K, Jensen JM. The natural history of outpatient alcohol and drug abuse treatment in a private healthcare setting. Alcohol Clin Exp Res. 1996; 20:847-852.
15. Wickizer T, Maynard C, Atherly A, et al. Completion rate of clients discharged from drug and alcohol treatment programs in Washington State. Am J Public Health. 1994; 84:215-221.
16. Verinis J. Characteristics of patients who continue with alcohol outpatient treatment. Int J Addictions. 1986; 21:25-31.
17. Volpicelli JR, Clay KL, Watson NT, O’Brien CP. Naltrexone in the treatment of alcoholism: Predicting response to naltrexone. J Clin Psychiatry. 1995; 56:39-44.
18. Volpicelli JR, Watson NT, King AC, Sherman CE. Effect of naltrexone on alcohol “high” in alcoholics. Am J Psychiatry. 1995; 152:613-615.
19. Fuller R, Branchey L, Brightwell DR, et al. Disulfiram treatment of alcoholism: A Veterans Administration cooperative study. JAMA. 1986; 256:1449-1455.
20. Volpicelli JR, O’Brien CP, Alterman AI, Hayashida M. Naltrexone and the treatment of alcohol dependence: Initial observations. In: Reid, LD Ed. Opioids, Bulimia, and Alcohol Abuse & Alcoholism. New York: Springer-Verlag, 1990, pp. 195-214.
21. Volpicelli JR, Alterman AI, Hayashida M, O’Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992; 49:876-880.
22. Volpicelli JR, Rhines KC, Rhines JS, et al. Naltrexone and alcohol dependence: Role of subject compliance. Arch Gen Psychiatry. 1997; 54:737-742.
23. O’Malley SS, Jaffe AJ, Chang G, et al. Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Arch Gen Psychiatry. 1992; 49:881-887.
24. Berg BJ, Pettinati HM, Volpicelli JR. A risk-benefit assessment of naltrexone in the treatment of alcohol dependence. Drug Saf. 1996; 15:274-282.
25. O’Brien CP, Volpicelli LA, Volpicelli JR. Naltrexone in the treatment of alcoholism: A clinical review. Alcohol. 1996; 13:35-39.
26. Volpicelli JR, Pettinati HM, McLellan AT, O’Brien CP. BRENDA manual: Compliance enhancement techniques with pharmacotherapy for alcohol and drug dependance. New York: Guilford. In press.
27. Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol. 1997;58:7-29.
28. Nunes EV, McGrath PJ, Quitkin FM, et al. Imipramine treatment of alcoholism with comorbid depression [see comments]. Am J Psychiatry. 1993; 150:963-965.
29. Mason BJ, Kocsis JH, Ritvo EC, Cutler RB. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression [see comments]. JAMA. 1996; 275:761-767.
30. Kranzler H, Burleson J, Del Boca K, et al. Buspirone treatment of anxious alcoholics: A placebo-controlled trial. Arch Gen Psychiatry. 1994; 51:720-731.
31. Eisen S, Miller D, Woodward R, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1991; 151:1236-1237.
32. Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989; 261:3273-3277.
33. Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. Am J Hosp Pharm. 1991; 48:1978-1988.